AKT antibody orb213545 from Biorbyt

Product Specs
ItemAKT antibody
CompanyBiorbyt
Price Pricing Info Supplier Page
Catalog Numberorb213545
Quantity30 µl, 100 µl, 200 µl
ApplicationsIH, WB
Conjugate/TagUnconjugated
ReactivityHuman, Mouse, Primate, Rat
TargetAKT1
HostRabbit
NCBI Full Gene NameAKT serine/threonine kinase 1, thymoma viral proto-oncogene 1
NCBI Gene AliasesRac, RAC-ALPHA, PKB-ALPHA, PRKBA, Akt, PKB, LTR-akt, PKB/Akt, AKT, PKBalpha, RAC
ClonalityPolyclonal
ImmunogenKLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human AKT. The exact sequence is proprietary
FormatLiquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide
StorageShipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles

Application Dilutions: WB: 1-500-1-1000, IHC-P: 1-100-1-200

7, Signet Court

Swann Road

Cambridge, Cambridgeshire CB5 8LA

United Kingdom

Phone: +44(0)1223 815 212
+44(0)1223 280 240 (fax)
+44(0)1223 280 240

Email: info@biorbyt.com
support@biorbyt.com
accounts@biorbyt.com

(1) miR-10a overexpression aggravates renal ischemia–reperfusion injury associated with decreased PIK3CA expressionBMC NephrologyDecember 1, 2020Dongsheng Xu, Wenjun Li, Tao Zhang, Gang Wangorb228203, Biorbyt), PI3K (1:800, orb137259, Biorbyt), p-PI3K (1:800, orb338965, Biorbyt), Akt (1:800, orb213545, Biorbyt), p-Akt (1:800, orb222951, Biorbyt), and β-actin (1:2000, orb178392, Biorbyt). All primary

(2) Downregulation of miR-34a Promotes Proliferation and Inhibits Apoptosis of Rat Osteoarthritic Cartilage Cells by Activating PI3K/Akt PathwayClinical Interventions in AgingMarch 16, 2020Haitao Tao, Lei Cheng, Ruixiang Yangorb137259, Biorbyt, Cambridge, UK), p-PI3K (1:1000, orb338965, Biorbyt, Cambridge, UK), Akt (1:1000, orb213545, Biorbyt, Cambridge, UK), p-Akt (1:1000, orb222951, Biorbyt, Cambridge, UK) and β-actin (1:1000, ABIN2854709,

(3) Silencing of miR-223 expression inhibits the apoptosis of H₂O₂-induced cardiomyocytes by increasing the activity of the IGF-1R/PI3K/AKT pathwayEuropean Journal of InflammationJanuary 1, 2020Qianqian Zhou, Yufen Li, Tianjin Guab39675; Abcam, Cambridge, UK), PI3K (1:800; orb137259; Biorbyt), p-PI3K (1:800; orb338965; Biorbyt), AKT (1:900; orb213545; Biorbyt), p-AKT (1:900; orb222951; Biorbyt), and β-actin (1:1800; orb178392; Biorbyt). PVDF membranes

BMC Nephrology